Profund Advisors’s Integra LifeSciences IART Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2022
Q2
Sell
-4,365
Closed -$280K 1160
2022
Q1
$280K Buy
4,365
+163
+4% +$10.5K 0.01% 995
2021
Q4
$281K Sell
4,202
-113
-3% -$7.56K 0.01% 1031
2021
Q3
$295K Sell
4,315
-453
-10% -$31K 0.01% 969
2021
Q2
$325K Buy
4,768
+34
+0.7% +$2.32K 0.01% 991
2021
Q1
$327K Sell
4,734
-187
-4% -$12.9K 0.01% 904
2020
Q4
$319K Sell
4,921
-1,213
-20% -$78.6K 0.01% 787
2020
Q3
$290K Buy
+6,134
New +$290K 0.01% 682
2020
Q1
Sell
-5,817
Closed -$339K 956
2019
Q4
$339K Sell
5,817
-49
-0.8% -$2.86K 0.01% 838
2019
Q3
$352K Sell
5,866
-1,805
-24% -$108K 0.02% 822
2019
Q2
$428K Sell
7,671
-756
-9% -$42.2K 0.02% 718
2019
Q1
$470K Buy
8,427
+2,508
+42% +$140K 0.02% 656
2018
Q4
$267K Sell
5,919
-2,902
-33% -$131K 0.02% 839
2018
Q3
$581K Sell
8,821
-212
-2% -$14K 0.02% 685
2018
Q2
$582K Sell
9,033
-4,242
-32% -$273K 0.02% 682
2018
Q1
$735K Buy
13,275
+2,682
+25% +$148K 0.03% 570
2017
Q4
$507K Sell
10,593
-675
-6% -$32.3K 0.02% 810
2017
Q3
$569K Buy
11,268
+979
+10% +$49.4K 0.02% 690
2017
Q2
$561K Sell
10,289
-1,060
-9% -$57.8K 0.03% 665
2017
Q1
$478K Sell
11,349
-2,365
-17% -$99.6K 0.02% 878
2016
Q4
$588K Buy
13,714
+4,354
+47% +$187K 0.03% 784
2016
Q3
$386K Buy
9,360
+1,520
+19% +$62.7K 0.02% 936
2016
Q2
$313K Sell
7,840
-4
-0.1% -$160 0.02% 1100
2016
Q1
$264K Sell
7,844
-2,806
-26% -$94.4K 0.01% 1170
2015
Q4
$361K Buy
10,650
+3,592
+51% +$122K 0.02% 830
2015
Q3
$210K Sell
7,058
-5,461
-44% -$162K 0.01% 1078
2015
Q2
$345K Sell
12,519
-3,041
-20% -$83.8K 0.01% 1027
2015
Q1
$392K Buy
15,560
+4,903
+46% +$124K 0.02% 1066
2014
Q4
$236K Buy
+10,657
New +$236K 0.01% 1265
2014
Q3
Sell
-13,013
Closed -$250K 1378
2014
Q2
$250K Buy
13,013
+257
+2% +$4.94K 0.01% 1315
2014
Q1
$240K Sell
12,756
-13,974
-52% -$263K 0.01% 1346
2013
Q4
$521K Buy
26,730
+4,377
+20% +$85.3K 0.02% 999
2013
Q3
$368K Buy
+22,353
New +$368K 0.02% 1159